Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Linagliptin/metformin
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Linagliptin 2.5mg / Metformin 1g tablets
0601023AFAAABAB
|
Linagliptin/metformin | Linagliptin/metformin | Endocrine System | 12,702 |
|
Linagliptin 2.5mg / Metformin 850mg tablets
0601023AFAAAAAA
|
Linagliptin/metformin | Linagliptin/metformin | Endocrine System | 2,363 |
|
Jentadueto 2.5mg/1000mg tablets
0601023AFBBABAB
|
Jentadueto | Linagliptin/metformin | Endocrine System | 459 |
|
Jentadueto 2.5mg/850mg tablets
0601023AFBBAAAA
|
Jentadueto | Linagliptin/metformin | Endocrine System | 137 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.